Skip to main content
. 2022 Jun 21;12:906778. doi: 10.3389/fonc.2022.906778

Figure 1.

Figure 1

The dynamic trend of clinical parameters of PLC patients from 2003 to 2020. (A) The proportions of HCC, HBV seropositivity, HCV seropositivity, and early BCLC stage in PLC. (B) The proportions of HBV seropositivity, HCV seropositivity, and early BCLC stage in HCC. (C) The dynamic trends of 1-year, 3-year, and 5-year survival rates. Linear trends were calculated by using Cochran-Armitage test. BCLC, Barcelona Clinic Liver Cancer; HBV, hepatitis B virus; HCV, hepatitis C virus; HCC, hepatocellular carcinoma.